Citation Impact
Citing Papers
A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
2010
High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
2009
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
2012
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
2017 Standout
Triple negative breast cancer: unmet medical needs
2010
Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy
2008
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Triple-negative breast cancer: disease entity or title of convenience?
2010
Triple negative tumours: a critical review
2007
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
2009
Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypes
2009
Triple-Negative Breast Cancer
2010 Standout
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
2010
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
1997 Standout
Mdm2 promotes the rapid degradation of p53
1997 StandoutNature
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
2011
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
2009
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
2000 StandoutNobel
Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1
1997
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
Ovarian cancer
2014 Standout
Classification of papillomaviruses
2004 StandoutNobel
Allosteric activation of latent p53 tetramers
1994
Cushing's syndrome
2015 Standout
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
1998 StandoutNatureNobel
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Li-Fraumeni syndrome – a molecular and clinical review
1997
Lessons from Hereditary Colorectal Cancer
1996 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Histological and molecular types of breast cancer: is there a unifying taxonomy?
2009
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
DNA Damage, Aging, and Cancer
2009 Standout
Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype
2010
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
2010 Standout
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer
2009
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Apoptosis
2002 Standout
Clinical Implications of the p53 Tumor-Suppressor Gene
1993
The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry
1996
Emerging Biological Principles of Metastasis
2017 Standout
EMT: 2016
2016 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Gene-Expression Signatures in Breast Cancer
2009
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Clinical implications of p53 mutations
1999
The regulation of p53 function: Steiner award lecture
1994
Oncogenic DNA viruses
2001 StandoutNobel
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Human papillomavirus infections in skin cancers
1998
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Cushing's syndrome
2006 Standout
The Emerging p53 Gene Family
1999 StandoutNobel
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis
2015
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple‐negative and basal‐like breast cancers
2011
The tumore suppressor p53
1993
Deconstructing the molecular portraits of breast cancer
2010
Genomic instability in breast cancer: Pathogenesis and clinical implications
2010
Nuclear Accumulation of Mutated β-Catenin in Hepatocellular Carcinoma Is Associated with Increased Cell Proliferation
1999
Apoptosis: A Review of Programmed Cell Death
2007 Standout
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.
1997
An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma
2001
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Basal-Like Breast Cancer: A Critical Review
2008
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Wnt signaling and cancer
2000 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Breast Cancer Treatment
2019 Standout
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
2008
A comparison of the biological activities of wild‐type and mutant p53
1993
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
2015
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties
2021 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1 -mutated basal-like breast cancer
2007
Works of C E Gillett being referenced
Determination of cell proliferation
1995
BRCA1 dysfunction in sporadic basal-like breast cancer
2006
Abnormal expression of wild type p53 protein in normal cells of a cancer family patient
1992
The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients.
2004
Correlation of PIK3CA mutation-associated gene expression signature (PIK3CA-GS) with deactivation of the PI3K pathway and with prognosis within the luminal-B ER+ breast cancers
2009